Greatest Fund Ever? Simons’ Surprising Streak Persists
Renaissance Technologies’ Medallion Fund defies the odds by continuing to post extraordinary gains while founder Jim ...
Recognize when index signals hint at a trend reversal and how to adjust exposure accordingly. This guidance helps protect gains and minimize losses.
24,330 articlesRenaissance Technologies’ Medallion Fund defies the odds by continuing to post extraordinary gains while founder Jim ...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
A major hedge-like fund reduced its BlackLine stake, sending the stock lower. This article breaks down the why, what ...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Three AI-powered models weigh two extreme BTC futures for 2026: a downturn to $30,000 or a rally to $100,000. The art...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...
A solid one-day move in Venture Global stock rose today as analysts lifted price targets and LNG demand expectations ...
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Space companies can soar one day and stumble the next. This article breaks down why spacex (spcx) stock plunged, what...